Oral Therapy – Talk Bio

Actionable Insights Powered by AI

Merck’s Oral PCSK9 Inhibitor Enlicitide Significantly Reduces LDL Cholesterol in Phase 3 Trials

2 months ago talkbio0Tagged Administration of prophylactic statin, cholesterol, CORALreef, CORALreef AddOn, enlicitide, HeFH, Hypercholesterolemia, Familial, Hyperlipidemia, LDL-C, Merck, Oral Therapy, PCSK9 inhibitor

Merck; PCSK9 inhibitor; enlicitide; phase 3 trials; cholesterol; LDL-C; oral therapy; hyperlipidemia; familial hypercholesterolemia; CORALreef HeFH; CORALreef AddOn; statin therapy

Syntis Bio Launches Revolutionary Oral Therapy to Mimic Weight-Loss Surgery

1 year ago talkbio0Tagged Bio, Diabetes, Digestion, drug absorption, gastric bypass surgery, Intestines, Metabolic Control, Obesity, Oral Therapy, SYNT-101, Syntis, weight-loss surgery

Syntis Bio, weight-loss surgery, oral therapy, obesity, diabetes, rare diseases, SYNT-101, gastric bypass surgery, small intestine, metabolic control, digestion, drug absorption.